Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination Therapy
Roman Kosoy(University of California, Davis), Mayte Suárez‐Fariñas(Rockefeller University), Judy H. Cho(Cedars-Sinai Medical Center), Jean‐Frédéric Colombel(Mount Sinai Hospital), Bruce E. Sands(Icahn School of Medicine at Mount Sinai), Marla C. Dubinsky(Icahn School of Medicine at Mount Sinai), Adeeb Rahman(Immunai (United States)), Won‐Min Song(Center for Information Technology), Carrie Brodmerkel(Janssen (United States)), Andrew Kasarskis(Icahn School of Medicine at Mount Sinai), Ryan C. Ungaro(Feinstein Institute for Medical Research), Jacqueline Perrigoue(Johnson & Johnson (United States)), Ruiqi Huang(Icahn School of Medicine at Mount Sinai), Lauren Peters(Sema4 (United States)), Saurabh Mehandru(Icahn School of Medicine at Mount Sinai), Seunghee Kim‐Schulze(Icahn School of Medicine at Mount Sinai), Carmen Argmann(Icahn School of Medicine at Mount Sinai), Eric E. Schadt(Program for Appropriate Technology in Health), El-ad David Amir(Icahn School of Medicine at Mount Sinai), Aleksandar Stojmirović(Janssen (United States)), Ke Hao(Boston University), Mark Curran(Janssen (United States)), Joshua R. Friedman(Spark Therapeutics (United States))
Cited by 35
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k